Tag: Exosomes
The Cell Factory To Present Preclinical Results For The CF-MEV-132 Extracellular Vesicles Drug Candidate
The Cell Factory and the University of Padova, Italy have confirmed, preclinically, the long-term therapeutic effect of the CF-MEV-132 extracellular vesicles drug candidate for the treatment of bronchopulmonary dysplasia (BPD). The results demonstrate a full regeneration of animal lungs...
Capricor Presented Data On Allogeneic Cell-Derived Therapies At Gordon Research Conference
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, founded in 2005, based in Los Angeles, focused on the discovery, development and commercialization of first-in-class biological therapeutics for the treatment of rare disorders. Capricor’s lead candidate, CAP-1002, is an allogeneic...
